A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED)

NCT00418613 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

266

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: MK633
DRUG: Comparator: Placebo (unspecified)

Sponsor

Merck Sharp & Dohme LLC